Acne and Mood: Impact of Treatment on Depression, Anxiety, and Sexual Function

NCT03921476 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-10-09

No results posted yet for this study

Summary

This study seeks to examine if there is any relationship between spironolactone use prescribed for acne vulgaris and depression, anxiety, and/or sexual function.

Conditions

  • Acne Vulgaris

Interventions

OTHER

Online survey

Online survey completion through Northwestern's REDCap

Sponsors & Collaborators

Principal Investigators

  • Bethanee Schlosser, MD · Northwestern University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03921476 on ClinicalTrials.gov